Description
Tesamorelin Disposable Pen — Opti-Gen Peptides
Laboratory accessory kit. For research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.
Not a patient injection device.
Empty disposable pen body supplied in a fitted case with four 4 mm needle attachments, branded Opti-Gen Peptides. Sold only as a laboratory handling accessory. It does not contain tesamorelin unless a separate RUO vial is purchased and documented on its own COA.
Licensed tesamorelin (Egrifta) is a separate prescription medicine. This kit is not that product. Must not be used to administer substances to people or animals.
Identification
| Product name | Tesamorelin Disposable Pen (accessory kit) |
| Supplier | Opti-Gen Peptides |
| Contents | 1 × empty disposable pen body; 4 × 4 mm needle attachments; fitted case |
| Peptide fill | None in this kit |
| Related research peptide (sold separately) | Tesamorelin — trans-3-hexenoyl-GHRH(1–44) (CAS 218949-48-5) |
| Intended use | Laboratory accessory only |
Not sermorelin. Not CJC-1295. Not Egrifta.
Quality / storage
Store dry as laboratory hardware. No assembly, priming, click-count or administration instructions on this page. Needles are not supplied for clinical or consumer injection.
Published research context (not product claims)
Tesamorelin is a stabilised GHRH(1–44) analogue. Receptor papers use it as a GHRH-receptor research ligand.
Clinical-development work produced authorised medicines for specified indications. Those authorisations apply only to approved drug products.
Egrifta-type labelling for HIV-associated lipodystrophy must not be copied onto this pen kit.
GHRH analogues may be WADA-restricted. There is no authorisation to market this kit as a UK medicine or patient device.
UK notice
18+. Buyer confirms lawful laboratory use only and will not use or resell this kit for unauthorised human or animal administration.
Reviews
There are no reviews yet.